Opinion|Videos|May 29, 2024
Criteria for Diagnosing Alzheimer Disease and the Role of Testing
Focusing on the diagnosis of Alzheimer disease, the panel discusses key diagnostic criteria, testing practices, and the role of genetic testing.
Advertisement
Episodes in this series
- Discuss the key diagnostic criteria for AD. How do you differentiate between AD and other forms of dementia during the diagnostic process?
- What tests might providers order to help establish a diagnosis of AD? [e.g., biomarker, genetic, and neuroimaging tests.]
- Do you consider the results of genetic testing when selecting among available treatment options for patient with AD?
Advertisement
Related to this article
Pharmacists outline new oncologic therapeutics, from pancreatic cancer to myeloma, and what high prices and crowded markets mean for payers.
Invivyd presented preclinical IDWeek 2026 data on VMS063, an investigational antibody that neutralized B3 and D8 measles variants in vitro.
Sphingolipid profiles in plasma and breath condensate differed between IPF and f-HP and tracked with disease severity, CHEST 2026 data show.
The FDA granted accelerated approval to the first plasmid DNA-based immunotherapy for adults with recurrent respiratory papillomatosis (RRP).
October's FDA approvals included the introduction of 5 non-oncology treatment options across specialties.
A phase 4 study found 69% of patients with OAB were consistently satisfied with vibegron at 12 months, with exploratory persistence of 59.8%.
Initial frontal fibrosing alopecia treatment was largely similar in Black and White patients, though tetracycline use was higher in Black patients.
Advertisement
Advertisement
Trending on AJMC
1
Occasional Cannabis Use Linked to 40% Higher Odds of Stroke
2
Enlicitide LDL-C Lowering Holds Across Risk Levels Up to 2 Years
3
GLP-1 Use Tied to Lower Diabetes, CV Risk vs Metformin in Prediabetes
4
Invivyd Unveils Measles Antibody Candidate VMS063 at IDWeek 2026
5